Health Discovery Corporation (DWCM.OB) Awarded a $244,479.25 Qualifying Therapeutic Discovery Project (QTDP) Grant Under the Patient Protection and Affordable Care Act of 2010  
11/3/2010 10:35:27 AM

SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY) is pleased to announce that it has been awarded $244,479.25 by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of the company's SVM and RFE-SVM technology. The QTDP grant program provides support for innovative projects that are determined by the U.S. Department of Health and Human Services to have reasonable potential to result in new therapies, to treat areas of unmet medical need, or to prevent, detect, or treat chronic or acute diseases and conditions, or to reduce long-term health care costs in the United States, or to significantly advance the goal of curing cancer